Navigation Links
New FT-IR Spectrometer Series from Varian, Inc.
Date:3/31/2008

Unrivalled Performance Meets Simplicity for Routine and Research

Applications

PALO ALTO, Calif., March 31 /PRNewswire-FirstCall/ -- Varian, Inc. (NasdaqGS: VARI) announced today its new 600-IR series of FT-IR (Fourier Transform Infrared) spectrometers, microscopes and imaging solutions. The series comprises a range of products for both routine analyses and advanced research applications.

FT-IR spectroscopy provides a simple, fast analytical tool to identify or characterize samples in a wide range of applications from QA/QC testing of raw materials in pharmaceutical laboratories to the detection of trace amounts of explosives or narcotics in forensic analysis.

FT-IR spectroscopy also has the ability to reveal the chemical fingerprint of a material, even in mixtures, allowing multiple materials to be identified simultaneously. Commonly used with a wide range of accessories such as ATR (Attenuated Total Reflectance), microscopes and imaging, FT-IR has pioneered new applications in areas such as biotechnology, food and agriculture and homeland security.

The Varian 600-IR series of spectrometers deliver the highest energy throughput, making them the ideal solution for research or method development applications. Designed for unrivalled performance, this new range of spectrometers and microscopes enables users to run samples faster, while maintaining the highest accuracy and reproducibility, saving both time and money.

Combining power with simplicity, the Varian 600-IR series intuitive, easy- to-use software and "plug and play" hardware simplify analyses and maximize output for both novice and expert users. The ability for users to upgrade their new instrumentation ensures that they can purchase a system that fits their budget today and will meet their needs in the future.

"The 600-IR Series offers unrivalled performance under real world conditions," said Martin O'Donoghue, Senior Vice President, Scientific Instruments, Varian, Inc. "The combination of superior performance and reduced complexity offers information rich detection to users in a broad range of applications."

For more technical information about Varian's FT-IR instrumentation, please visit http://www.varianinc.com/products/

Varian, Inc. is a leading worldwide supplier of scientific instruments and vacuum technologies for life science and industrial applications. The company provides complete solutions, including instruments, vacuum products, laboratory consumable supplies, software, training and support through its global distribution and support systems. Varian, Inc. employs approximately 3,900 people worldwide and operates manufacturing facilities in North America, Europe and Asia Pacific. Varian, Inc. had fiscal year 2007 sales of $921 million, and its common stock is traded on the NASDAQ Global Select Market under the symbol, "VARI." Further information is available on the company's Web site: http://www.varianinc.com.

For More Information, Contact:

Public Relations

Varian, Inc.

650.424.3845

pr@varianinc.com


'/>"/>
SOURCE Varian, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Transave, Inc. Raises $35 Million Through Series D Convertible Preferred Stock Financing
2. Pieris Raises EUR 25 M (US$ 38 M) in Series B Financing Round
3. LigoCyte Pharmaceuticals Finalizes Agreement for $28M Series C Financing Round
4. Axial Biotech Meets Major Scientific Milestones; Receives $6 Million Tranche of Series B Financing
5. U.S. FDA Licenses DAPTACEL(R) Vaccine for the Fifth Consecutive Dose in the Pediatric DTaP Immunization Series
6. Mercury Therapeutics, Inc: Lead Series of Indirect AMPK Activators Licensed to Makoto Life Sciences
7. New nanotechnology television series does sweat the small stuff
8. BrainCells Inc. Completes $30 Million Initial Closing of Series B Financing
9. Cord Blood America Subsidiary Featured at NASCAR Sprint Cup Series Race
10. National Stem Cell Holding, Inc. to Present Keynote Address at The Stem Cell Partnering Series Inaugural Meeting in San Diego
11. The Diabetes Series 2008: Experts Speak About Developing Diabetes Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... In a ... Hospital in Denmark detail how a patient who developed lymphedema after being treated for ... The results could change the paradigm for dealing with this debilitating, frequent side effect ...
Breaking Biology Technology:
(Date:5/12/2016)... May 12, 2016 WearablesResearch.com , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
Breaking Biology News(10 mins):